Inicio › Enfermedad de Crohn › Kansas
Ensayos clínicos de Enfermedad de Crohn en Kansas
11 estudios sobre Enfermedad de Crohn buscan participantes en Kansas.
Ciudades en Kansas
Texto oficial del estudio (inglés)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- y 7 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345A Study of SL-325 in Crohn's Disease Patients
- Clinical Trial Site, Kansas City
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07753850A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Kansas Medical Center ( Site 5091), Kansas City
- Cotton O'Neil Digestive Health Center ( Site 5033), Topeka
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT06430801A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07483099A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Kansas Gastroenterology, LLC, Wichita
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07196722A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Cotton-O'Neil Clinical Research Center, Topeka
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07499232A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center, Kansas City
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT06233461A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400006, Kansas City
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT06958536A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Hutchinson Clinic, Hutchinson
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06581328An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center-Site Number: 8400110, Kansas City
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 21 oct 2026 · NCT07184931De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.